Cell Injury & Adaptation

The cell is the fundamental unit of disease — every pathology ultimately traces back to how a cell responds to stress. This topic anchors all of General Pathology, and NEET PG loves it for its tight, fact-dense concepts: types of necrosis, the apoptosis-vs-necrosis divide, adaptive responses, and the morphologic and biochemical markers of injury.

Overview: the spectrum of cellular response to stress

When a cell faces an altered environment or noxious stimulus, it has a graded set of options depending on the type, severity, and duration of the insult, and on the vulnerability of the cell type.

Normal cell → (increased demand / stress) → Adaptation → (limit exceeded / injurious stimulus) → Reversible injury → (persistent / severe) → Irreversible injury → Cell death (necrosis or apoptosis)

Response	Trigger	Reversible?	Example
Adaptation	Physiologic/pathologic stress within capacity	Yes	LV hypertrophy in HTN
Reversible injury	Mild/transient injury	Yes	Cellular swelling, fatty change
Irreversible injury	Severe/persistent injury	No	Loss of membrane integrity
Cell death	Lethal injury	No	Necrosis / apoptosis

High-yield: Whether an injury is reversible or irreversible hinges on two morphologic "points of no return" — severe mitochondrial dysfunction and profound disturbance of membrane function (plasma & lysosomal). Once these occur, the cell is committed to death.

Cellular adaptations

Adaptations are reversible changes in size, number, phenotype, metabolic activity, or function of cells in response to changes in their environment.

1. Hypertrophy

Increase in cell size → increase in organ size. No new cells; the cell synthesises more structural proteins and organelles. Occurs in permanent (non-dividing) tissues — cardiac & skeletal muscle.

• Physiologic: gravid uterus (also has hyperplasia), skeletal muscle of bodybuilders.
• Pathologic: LV hypertrophy in hypertension / aortic stenosis.
• Mechanism: mechanical sensors → growth factors (TGF-β, IGF-1) → vasoactive agents (angiotensin II, endothelin) → switch to fetal/neonatal gene programme (e.g. re-expression of β-myosin heavy chain, ANP).

High-yield: Atrial natriuretic peptide (ANP) is re-expressed in cardiac hypertrophy — a classic "fetal gene" reactivation marker.

2. Hyperplasia

Increase in cell number due to proliferation. Occurs only in tissues with dividing (labile/stable) cells.

• Physiologic — hormonal (breast at puberty/pregnancy) or compensatory (liver regeneration after partial hepatectomy).
• Pathologic — excessive hormonal/growth factor stimulation: endometrial hyperplasia, benign prostatic hyperplasia (BPH).

High-yield: Pathologic hyperplasia (e.g. endometrial) constitutes fertile soil for cancer, BUT BPH does not progress to prostate cancer. Hyperplasia remains controlled and regresses if the stimulus is removed — this distinguishes it from neoplasia.

3. Atrophy

Decrease in cell size and number → shrunken organ. Causes: disuse, denervation, loss of blood supply, inadequate nutrition, loss of endocrine stimulation, ageing (senile atrophy), pressure.

Mechanism: reduced protein synthesis + increased protein degradation via the ubiquitin–proteasome pathway and autophagy (autophagic vacuoles). Residue of autophagy = lipofuscin ("wear-and-tear" pigment, brown atrophy of heart/liver).

4. Metaplasia

Reversible replacement of one differentiated (adult) cell type by another. It is a reprogramming of stem cells, not transdifferentiation of mature cells.

Site	From → To	Stimulus
Bronchus (smoker)	Ciliated columnar → squamous	Cigarette smoke
Lower oesophagus (Barrett)	Squamous → columnar (intestinal)	GERD/acid
Cervix	Columnar → squamous	Low pH
Bladder/ureter	Transitional → squamous	Schistosoma, stones
Connective tissue	Fibroblast → bone/cartilage (myositis ossificans)	Trauma

High-yield: Metaplasia is adaptive but predisposes to malignancy — Barrett oesophagus → adenocarcinoma; bronchial squamous metaplasia → squamous cell carcinoma. Vitamin A deficiency causes squamous metaplasia of respiratory/glandular epithelium; excess Vitamin A inhibits it.

High-yield: Dysplasia is NOT metaplasia. Dysplasia = disordered growth with atypia, a precancerous change. Metaplasia is orderly substitution by another mature epithelium.

Causes (etiology) of cell injury

A useful mnemonic: "HIIIING POM" — Hypoxia, Infectious, Immunologic, Inflammatory, Nutritional, Genetic, Physical agents, O = chemicals/drugs, M = ageing. The single most common and most important cause is hypoxia/ischaemia.

Hypoxia vs ischaemia: Hypoxia = ↓ oxygen with preserved blood flow (anaemia, CO poisoning, high altitude). Ischaemia = ↓ blood flow → loss of O₂ and of glucose/substrate and failure to remove metabolites. Ischaemia injures faster and more severely than hypoxia because anaerobic glycolysis also stops once substrate runs out.

Pathophysiology — biochemical mechanisms

Four intracellular systems are especially vulnerable: (1) aerobic respiration/ATP, (2) membrane integrity, (3) protein synthesis, (4) DNA & cytoskeleton.

Sequence in ischaemic (hypoxic) injury — stepwise

1. ↓ Oxidative phosphorylation → ↓ ATP.
2. ↓ ATP → Na⁺/K⁺-ATPase fails → Na⁺ and water enter → cellular swelling (earliest morphologic change) and ER swelling.
3. Switch to anaerobic glycolysis → glycogen depletion, ↑ lactic acid → ↓ intracellular pH → clumping of nuclear chromatin.
4. Detachment of ribosomes from RER → ↓ protein synthesis → lipid deposition (fatty change).
5. If reversible at this point and oxygen restored → recovery. If persists →
6. Massive Ca²⁺ influx (mitochondrial & cytosolic) → activates phospholipases (membrane damage), proteases (cytoskeleton/membrane), endonucleases (DNA), ATPases (↓ ATP further).
7. Mitochondrial permeability transition pore opens → no ATP regeneration; cytochrome c leaks.
8. Membrane damage → enzymes leak out (CK, troponin, transaminases); lysosomal enzymes leak in → enzymatic digestion → necrosis.

High-yield: Cellular swelling (hydropic/vacuolar change) is the FIRST and most universal manifestation of reversible injury; membrane defects mark the transition to irreversibility. Increased cytosolic Ca²⁺ is the central executioner of injury.

Free radical (oxidative) injury

Reactive oxygen species: superoxide (O₂•⁻), hydrogen peroxide (H₂O₂), hydroxyl radical (•OH — most damaging), and peroxynitrite. Generated in inflammation, radiation, reperfusion, chemical metabolism (e.g. CCl₄ → CCl₃• causing fatty liver), redox-reactive drugs.

Effects: lipid peroxidation of membranes, protein cross-linking/oxidation, DNA damage (8-oxo-guanine → mutations).

Defences: enzymes superoxide dismutase (SOD → H₂O₂), catalase (H₂O₂ → H₂O + O₂), glutathione peroxidase; antioxidants vitamins A, C, E; metal-binding proteins (transferrin, ferritin, ceruloplasmin).

High-yield: Reperfusion injury — restoring blood flow to ischaemic tissue can paradoxically worsen damage via a burst of ROS, Ca²⁺ overload, complement activation and neutrophil influx. Classic in MI thrombolysis/PCI and stroke.

Other mechanisms

• Chemical injury: direct (e.g. mercuric chloride binds membrane proteins) or via toxic metabolites (CCl₄, paracetamol → NAPQI in liver).
• Misfolded proteins / ER stress → unfolded protein response; if overwhelmed → apoptosis.
• DNA damage → p53-mediated apoptosis.

Morphology of reversible injury

• Cellular (hydropic) swelling — small clear vacuoles (distended ER); organ pale, heavy, turgid.
• Fatty change (steatosis) — accumulation of triglyceride vacuoles, esp. liver, heart, kidney. Causes: alcohol, obesity, diabetes, toxins, protein malnutrition (kwashiorkor).

Ultrastructure: plasma membrane blebbing, mitochondrial swelling, ER dilatation, ribosomal detachment.

Necrosis vs apoptosis — the most-tested comparison

Feature	Necrosis	Apoptosis
Cause	Always pathologic	Physiologic OR pathologic
Cell size	Swollen (enlarged)	Shrunken
Nucleus	Pyknosis → karyorrhexis → karyolysis	Fragmentation into nucleosome-sized pieces
Plasma membrane	Disrupted (leaky)	Intact, altered orientation
Cell contents	Leak out	Retained in apoptotic bodies
Inflammation	Yes (prominent)	No
Energy (ATP)	ATP-independent	ATP-dependent (active)
DNA breakdown	Random smear (gel)	Ladder pattern (180–200 bp)
Caspases	Not central	Central executioners

High-yield: Nuclear changes of necrosis in order — Pyknosis (condensation) → Karyorrhexis (fragmentation) → Karyolysis (dissolution/fading). Apoptosis shows an internucleosomal DNA ladder on electrophoresis; necrosis shows a smear.

Apoptosis pathways

• Intrinsic (mitochondrial): withdrawal of growth factors, DNA damage, misfolded proteins → ↑ pro-apoptotic BAX/BAK, ↓ anti-apoptotic BCL-2/BCL-XL → mitochondrial pore → cytochrome c release → apoptosome (Apaf-1 + caspase-9) → executioner caspase-3/6/7.
• Extrinsic (death receptor): Fas (CD95)–FasL or TNFR1 → caspase-8 → executioner caspases. Linked to intrinsic via Bid.
• Recognition: phosphatidylserine flips to outer leaflet (Annexin V binding marker) → phagocytosis without inflammation.

High-yield: BCL-2 inhibits apoptosis — its overexpression (t(14;18)) underlies follicular lymphoma. Caspases are the central proteases of apoptosis; cytochrome c initiates the intrinsic pathway.

Other forms of cell death (newer, increasingly asked)

• Necroptosis — programmed but morphologically necrotic; uses RIP1/RIP3, MLKL; caspase-independent.
• Pyroptosis — caspase-1, inflammasome, IL-1β release (intracellular microbes).
• Ferroptosis — iron-dependent lipid peroxidation; excess intracellular iron/ROS.

Types of necrosis — exam favourite

Type	Key cause/site	Gross/Micro	Mechanism
Coagulative	Ischaemic infarcts of all solid organs except brain (heart, kidney, spleen)	Firm; architecture preserved (ghost outlines), anucleate cells	Denaturation of proteins predominates
Liquefactive	Brain infarct, bacterial/fungal abscess	Soft, liquid, pus	Enzymatic digestion predominates
Caseous	TB, some fungi	"Cheese-like", friable; granuloma with central amorphous debris	Combined — architecture lost
Fat	Acute pancreatitis, breast trauma	Chalky-white saponification	Lipase → FFA + Ca²⁺ soaps
Fibrinoid	Immune vasculitis, malignant HTN, PAN	Bright pink amorphous in vessel walls	Immune complexes + fibrin
Gangrenous	Limb (lower leg), bowel	Dry vs wet vs gas	Coagulative ± superimposed liquefactive (infection)

High-yield: The brain is the exception — ischaemic injury to the CNS produces liquefactive (not coagulative) necrosis, because of high lipid/enzyme content and scant connective tissue.

High-yield: Caseous necrosis is the hallmark of tuberculosis; fat necrosis with saponification of acute pancreatitis (causes hypocalcaemia); fibrinoid necrosis of malignant hypertension and immune vasculitides.

Gangrene subtypes — flow: Tissue ischaemia → coagulative necrosis = dry gangrene → if bacterial infection supervenes → liquefaction = wet gangrene → if gas-forming organisms (Clostridium) → gas gangrene.

Intracellular accumulations & pathologic pigments (quick hits)

• Lipofuscin — yellow-brown "wear and tear" pigment; ageing/atrophy; NOT injurious.
• Melanin — only endogenous brown-black pigment formed in the body.
• Haemosiderin — iron storage; localized (bruise) or systemic (haemochromatosis); Prussian blue positive.
• Dystrophic calcification — in dead/damaged tissue with normal serum calcium (atheroma, TB nodes, dead parasites, aortic stenosis).
• Metastatic calcification — in normal tissue with hypercalcaemia (hyperparathyroidism, vit D excess, sarcoidosis, milk-alkali).

High-yield: Dystrophic = damaged tissue + normal Ca²⁺; Metastatic = normal tissue + high Ca²⁺. Psammoma bodies (papillary thyroid Ca, serous ovarian tumour, meningioma) are a form of dystrophic calcification.

Diagnosis & investigation (markers of cell death)

• Leakage of intracellular enzymes/proteins into blood = standard clinical evidence of necrosis: cardiac troponins I/T & CK-MB (MI), transaminases (AST/ALT) (hepatocyte injury), amylase/lipase (pancreatic acinar necrosis), CK & myoglobin (rhabdomyolysis).
• Apoptosis detection: TUNEL assay (DNA nicks), Annexin V (phosphatidylserine), DNA ladder on gel, caspase-3 immunostain.
• Light microscopy: increased eosinophilia (loss of basophilic RNA), nuclear changes (pyknosis/karyorrhexis/karyolysis), myelin figures.

High-yield: Troponin is the most sensitive & specific marker of myocyte necrosis (rises 3–4 h, peaks ~24 h, stays up to 7–10 days). Reperfusion produces contraction band necrosis (hypercontracted sarcomeres with Ca²⁺ influx).

Management / clinical correlation

There is no "drug of choice" for cell injury per se; management is cause-directed and aims to interrupt the pathway:

• Restore perfusion/oxygenation (reperfusion in MI/stroke — balance against reperfusion injury).
• Antioxidants / scavengers in specific poisonings — N-acetylcysteine for paracetamol overdose (restores glutathione, mops up NAPQI).
• Support failing systems; treat underlying infection/immune process.

Complications

• Loss of functional tissue (infarction → organ failure: MI, stroke, ATN).
• Scarring/fibrosis replacing dead parenchyma (permanent tissues).
• Release of intracellular contents → systemic effects (hyperkalaemia, AKI in rhabdomyolysis; hypocalcaemia in pancreatitis).
• Dystrophic calcification of necrotic foci; secondary infection of necrotic tissue (wet/gas gangrene, sepsis).

Key differentials & traps

• Hypertrophy vs hyperplasia: both increase organ size; hypertrophy = bigger cells (permanent tissue), hyperplasia = more cells (dividing tissue). Uterus in pregnancy shows both.
• Atrophy vs hypoplasia/aplasia: atrophy = shrinkage of a previously normal organ; hypoplasia/aplasia = developmental failure.
• Metaplasia vs dysplasia vs neoplasia: orderly substitution vs disordered atypical growth vs autonomous clonal proliferation.
• Coagulative vs liquefactive: site (solid organ vs brain/abscess) and architecture (preserved vs dissolved).
• Dystrophic vs metastatic calcification: tissue status & serum calcium.

Recently asked / exam angle

• Single best answer staples: "First change in reversible cell injury?" → cellular swelling. "Earliest biochemical event in hypoxia?" → ↓ ATP. "Point of no return / irreversibility marker?" → membrane (plasma + mitochondrial) damage; massive Ca²⁺ influx.
• Necrosis matching: TB → caseous; pancreatitis → fat; brain infarct → liquefactive; MI/kidney/spleen infarct → coagulative; malignant HTN/PAN → fibrinoid. These appear nearly every year.
• Apoptosis: "Pathway of cytochrome c release?" → intrinsic/mitochondrial. "Marker flipped to outer membrane?" → phosphatidylserine. "DNA ladder = ?" → apoptosis. "BCL-2 function?" → anti-apoptotic.
• Calcification: dystrophic vs metastatic distinction; psammoma body associations.
• Newer cell-death modes: ferroptosis (iron-dependent), pyroptosis (inflammasome/IL-1β), necroptosis (RIP3/MLKL) — increasingly seen in image/concept items.
• Pigments: lipofuscin = ageing/atrophy; the only endogenous brown pigment synthesised = melanin.
• Reperfusion injury and contraction band necrosis in MI — favourite linking question.

Rapid revision

1. Cellular swelling = earliest, universal sign of reversible injury; membrane damage = irreversibility.
2. ↓ ATP is the first biochemical event in hypoxia; ↑ cytosolic Ca²⁺ is the final common executioner.
3. Hydroxyl radical (•OH) is the most damaging ROS; defences = SOD, catalase, glutathione peroxidase.
4. Coagulative necrosis = solid-organ infarcts (architecture preserved); brain = liquefactive (the exception).
5. Caseous = TB; fat = pancreatitis (saponification, hypocalcaemia); fibrinoid = malignant HTN/vasculitis.
6. Necrosis nuclear sequence: pyknosis → karyorrhexis → karyolysis.
7. Apoptosis = shrunken cell, intact membrane, DNA ladder, no inflammation, caspase-driven, ATP-dependent.
8. BCL-2 anti-apoptotic (t(14;18) follicular lymphoma); cytochrome c triggers intrinsic apoptosis; phosphatidylserine flip marks cells for phagocytosis.
9. Metaplasia is reversible & arises from stem-cell reprogramming; vitamin A deficiency → squamous metaplasia.
10. Dystrophic calcification = damaged tissue + normal Ca²⁺; metastatic = normal tissue + high Ca²⁺.
11. Lipofuscin = wear-and-tear pigment of ageing/atrophy; brown atrophy of heart.
12. Troponin = best marker of myocyte necrosis; reperfusion → contraction band necrosis; N-acetylcysteine for paracetamol toxicity.